#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast angiosarcoma metastatic Graft versus host disease Huntington's disease Chondrodystrophy Vulval cancer Acute lymphocytic leukaemia recurrent Hereditary optic atrophy Chronic graft versus host disease in liver Peritoneal neoplasm Crohn's disease Colorectal adenocarcinoma Nephropathy Ependymoma Mycobacterium abscessus infection Adrenoleukodystrophy More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Hepatic angiosarcoma – Diagnostics Lymphangiosarcoma – Diagnostics Cholangitis sclerosing – Life with Disease Encephalitis autoimmune Fragile X syndrome – Basic Information Alveolar rhabdomyosarcoma – Life with Disease SAPHO syndrome – Diagnostics Cystic fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maraviroc Apadamtase Alfa Daridorexant Quercus Ilex Allergen Extract Tenecteplase 177LU-FAP-2286 Bt-001 Sibeprenlimab Amoxicillin Trihydrate Darovasertib Ribonucleic Acid K10 Amikacin AMO959 DAPIGLUTIDE ATUMELNANT Secukinumab Remifentanil Hydrochloride LUNSEKIMIG Sodium Acetate (1-13C) Ethanol, Anhydrous More therapies…

    Learn about Your Condition

    Liver transplant rejection Myocardial infarction Colorectal cancer stage IV Thrombocytosis Nodal osteoarthritis Ovarian cancer Ewing's sarcoma Mitral valve incompetence Metastatic malignant melanoma Cutaneous T-cell lymphoma Niemann-Pick disease Dengue fever Merycism Haemophilia Cushing's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Iron deficiency

  • Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Dried Ferrous Sulfate
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland

  • A Study of Ferric Carboxymaltose to Improve Exercise Ability in Patients with Pulmonary Hypertension and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    • Pulmonary hypertension
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Belgium

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency
    Spain

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Colecalciferol
    Italy

  • Study on the Effects of Intravenous Ferric Derisomaltose in Non-Anemic Iron Deficient Patients with Colorectal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Denmark
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!